Enzyme immunoassay kits for MHRA vaccine batch testing come from Serosep
- Medicines and Healthcare products Regulatory Agency (MHRA)
- London
- Open procedure, 1 bid
- 16 November 2026 to 14 November 2031
The Medicines and Healthcare products Regulatory Agency (MHRA) buys qualitative enzyme immunoassay testing kits from Serosep, a small business. The agency uses the kits to test batches of vaccines and reference reagents before release.
The MHRA has validated these exact products in its test methods, so it would not accept substitutes or equivalent brands.
The open tender weighted technical at 60%, commercial at 30% and social value at 10%. Serosep was the only bidder and was chosen in October 2026. The £150,000 contract runs for five years, and three one-year extensions could take it to November 2034.
Contract ends November 2031
- What
- Laboratory consumables, reagents and chemicals
- Supplier
- Serosep
- Value
- £150,000
- How it was bought
- Open procedure
- 1 bid
- Dates and next
- Nov 2026 to Nov 2031
- Option to Nov 2034